We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

HbA1c Test Misses Many Cases of Diabetes

By LabMedica International staff writers
Posted on 02 Apr 2019
Print article
Image: The glycated hemoglobin or HbA1c test should not be solely used to determine the prevalence of diabetes (Photo courtesy of the Alberta Diabetes Foundation).
Image: The glycated hemoglobin or HbA1c test should not be solely used to determine the prevalence of diabetes (Photo courtesy of the Alberta Diabetes Foundation).
A glucose tolerance test, also known as the oral glucose tolerance test, measures the body's response to sugar (glucose). In this test, a person's blood is taken after an overnight fast, and then again two hours after they drink a sugary drink. The glucose tolerance test can be used to screen for type 2 diabetes.

The glycated hemoglobin (HbA1c) test shows the average level of blood sugar over the past two to three months. People who have diabetes usually have this test to see whether their blood sugar levels have been staying within a target range. This test is also used to diagnose type 1 and type 2 diabetes. It is often used to diagnose diabetes because no fasting or any preparation is required.

Endocrinologists at the City of Hope's Diabetes and Metabolism Research Institute (Duarte, CA, USA) included 9,000 adults without a diabetes diagnosis in a new study. The participants got both an HbA1c test and an oral tolerance glucose test, and the team compared the results. They found the HbA1c test did not catch 73% of diabetes cases that were detected by the oral glucose test. They found race and ethnicity had a significant impact on the accuracy of HbA1c. It was more likely to detect abnormal glucose levels in non-Hispanic whites than in non-Hispanic blacks or Hispanics.

Maria Mercedes Chang Villacreses, MD, the lead author of the study, said, “Based on our findings, HbA1c should not be solely used to determine the prevalence of diabetes. It should be used in conjunction with the oral glucose test for increased accuracy. The HbA1c test said some people had normal glucose levels when they didn't. Our results indicated that the prevalence of diabetes and normal glucose tolerance defined solely by HbA1c is highly unreliable, with a significant tendency for underestimation of the prevalence of diabetes and overestimation of normal glucose tolerance.” The study was presented on March 23, 2019, at the Endocrine Society's annual meeting held in New Orleans, LA, USA.

Related Links:
City of Hope's Diabetes and Metabolism Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.